Approval of Devyser’s RHD product in Canada
Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted...
Fetal RHD screening NIPT | January 17, 2024
Top performance at high-throughput: Devyser RHD maintains high sensitivity within an automated, high-throughput setting in Sahlgrenska University Hospital Study
Over the past decade, there has been a wealth of research investigating the ideal approach to RHD genotyping, to determine RhD incompatibility between mother and fetus, which is one of the main...
Find out more
